Betting on cotton: Potential payoffs and economic risks of adopting transgenic cotton in West Africa

Falck-Zepeda, José Benjamin; Horna, J. Daniela; Smale, Mélinda

doi:10.22004/ag.econ.56962

Cited by 3 publications

(1 citation statement)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies (see for example Falck Zepeda et al, 2008a , b ; Smyth et al, 2014 ; Wesseler et al, 2017 ) point to the economic impact of time delays in GM adoption resulting in foregone benefits. In the BioRAPP study, a 5-year adoption delay was simulated due to possible slowdown in the R&D process, in regulatory decision-making and/or in actual technology adoption (e.g., due to delays in seed availability).…”

Section: Results: Case Study Synthesismentioning

confidence: 99%

Opportunities for Orphan Crops: Expected Economic Benefits From Biotechnology

Zambrano

Wood‐Sichra²,

Ruhinduka³

et al. 2022

Front. Plant Sci.

View full text Add to dashboard Cite

An enabling, evidence-based decision-making framework is critical to support agricultural biotechnology innovation, and to ensure farmers’ access to genetically modified (GM) crops, including orphan crop varieties. A key element, and often a challenge in the decision-making process, involves the balancing of identified potential risks with expected economic benefits from GM crops. The latter is particularly challenging in the case of orphan crops, for which solid economic data is scarce. To address this challenge, the International Food Policy Research Institute (IFPRI) in collaboration with local economists analyzed the expected economic benefits to farmers and consumers from the adoption of GM crops in 5 sub-Saharan African countries. This paper focuses on case studies involving insect-resistant cowpea in Nigeria and Ghana; disease-resistant cassava in Uganda and Tanzania; and disease-resistant banana in Uganda. Estimations from these case studies show substantial economic benefits to farmers and consumers from the timely adoption and planting in farmers’ fields of GM orphan crops. Our analysis also shows how the benefits would significantly be reduced by regulatory or other delays that affect the timely release of these crops. These findings underscore the importance of having an enabling policy environment and regulatory system—covering, among other elements, biosafety and food/feed safety assessment, and varietal release registration—that is efficient, predictable, and transparent to ensure that the projected economic benefits are delivered and realized in a timely manner.

show abstract

Section: Results: Case Study Synthesismentioning

confidence: 99%